Showing results (401-410 of 532) with videos related to

Sort By:
Pageof 54
Leukemia & Lymphoma|May 3, 2008
Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemiaXavier Leleu, Anne-Sophie Moreau, Edie Weller, et al.
British Journal of Haematology|December 22, 2015
Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective studyJorge J Castillo, Shirley D'Sa, Michael P Lunn, et al.
Blood|September 11, 2014
Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche modelMichaela R Reagan, Yuji Mishima, Siobhan V Glavey, et al.
Blood Advances|January 11, 2024
Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk populationDavid J Lee, Habib El-Khoury, Angela C Tramontano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180Steven P Treon, Leukothea Ioakimidis, Jacob D Soumerai, et al.
Blood|November 3, 2011
Defining the role of TORC1/2 in multiple myelomaPatricia Maiso, Yi Liu, Brittany Morgan, et al.
Blood|May 16, 2009
RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myelomaAbdel Kareem Azab, Feda Azab, Simona Blotta, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 27, 2003
Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic modelSammy Saab, David Ly, Jose Nieto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's MacroglobulinemiaMeletios Athanasios Dimopoulos, Morie A Gertz, Efstathios Kastritis, et al.
British Journal of Haematology|June 3, 2015
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinationsCindy Varga, Wanling Xie, Jacob Laubach, et al.
Pageof 54